Singapore: Mr Jeremy Yee, an independent non-executive director of China Cord Blood Corporation (CCBC), a provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, has resigned with immediate effect.

Upon Mr Yee's resignation, the board of China Cord Blood Corporation now consists of seven directors, including four independent directors. The company does not plan on filling Mr Yee's board position.

"On behalf of our board, I would like to thank Mr Yee for his contributions during his tenure on our board, and we wish him continued success in his endeavors," commented Mr Yuen Kam, chairman, CCBC. "Cordlife has been and continues to be our important strategic partner."